글로벌 소동물(체내) 이미징 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

소동물(In-Vivo) 이미징 시장 분석

소동물(체내) 영상 시장은 예측 기간 동안 빠르게 증가할 것으로 추정됩니다. 소동물 영상 작업은 다양한 체내 기술을 사용합니다. 이러한 기술은 인기를 얻고 있으며 작용 메커니즘을 정의하고 수용체를 표적으로 삼고 후생유전학 연구를 수행하는 데 사용되고 있습니다. 멀티모달 기기의 개발 및 사용은 최근 몇 년 동안 연구의 전임상 및 임상 단계에서 빠르게 증가했습니다. 이중 모달 또는 하이브리드 PET/CT 스캐너가 권장되지만 SPECT/CT 스캐너는 이미 정기적인 분석에 일반적으로 사용됩니다.

소동물(In-Vivo) 이미징 시장 규모

글로벌 소동물(In-Vivo) 영상 시장 규모는 2023년에 10억 6천만 달러로 평가되었으며, 2031년까지 19억 8천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR이 8.1%가 될 것으로 예상됩니다.

보고 범위 및 시장 세분화       

Small Animal (In-Vivo) Imaging Market Definition

Small animal imaging (in-vivo) devices are a new type of diagnostic tool that may be used to diagnose a wide range of diseases in laboratory animals. Cancer cell research, monitoring drug response during drug development, examining the bio-distribution patterns of new chemical entities, biomarker research in animal models, longitudinal studies, and other disciplines all use a variety of small animal imaging (in-vivo) technologies. These devices have grown in popularity, and they are mostly employed in epigenetic research, receptor targeting, and determining the mechanism of action.

Small Animal (In-Vivo) Imaging Market Dynamics

Drivers

Over the projected period, rising use of multimodal imaging instruments expected to increase the market. Moreover, the rising expenditure for the healthcare sector will enhance the small animal (in-vivo) imaging market growth.  

Furthermore, increasing adoption of non-invasive technology for small animal imaging projected to propel the market forward. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the small animal (in-vivo) imaging market. Also, increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of small animal (in-vivo) imaging market. Small animal imaging systems and reagents have a wide range of uses in oncology, especially with the rise in cancer incidence around the world. The rising frequency of cardiovascular disorders is likely to boost the global small animal imaging market's growth in the cardiology application area.

Opportunities

• Increase in Pharmaceutical Industry and R&D Expenditure

An increase in pharmaceutical industry and R&D expenditure will provide beneficial opportunities for the small animal (in-vivo) imaging market growth. The creation and usage of multimodal imaging devices has seen remarkable expansion in the ongoing evolution of imaging technology. Pharmaceutical businesses' increased R&D spending is a direct result of changing industry structure, particularly the rise of the biotechnology section.

Moreover, growing focus of manufacturers on the adoption of advanced technologies in field of healthcare and increase in the number of emerging markets will further provide beneficial opportunities for the small animal (in-vivo) imaging market growth during the forecast period.

Restraints/Challenges 

• Strict Regulations

The presence of strict regulations will impede the market’s growth rate during the forecast period. One of the greatest impediments to the small animal imaging business is strict regulation. Distinct countries' regulatory agencies have different sets of rules for the application of medical devices, leaving product makers in an unclear situation.

On the other hand, low healthcare expenditure in developing countries and the lack of common standards will challenge the small animal (in-vivo) imaging market. Additionally, the lack of skilled professionals and low awareness will restrain and further impede the growth rate of the market during the forecast period of 2024-2031.

This small animal (in-vivo) imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the small animal (in-vivo) imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Small Animal (In-Vivo) Imaging Market

The COVID-19 outbreak boosted the market for small animal (in-vivo) imaging.  The majority of patients infected with COVID-19 have mild to moderate symptoms and recover at home, but some demanded medical intervention. COVID-19 appears to have a significant impact on the market.

In order to contain the COVID-19 spread, numerous governments enforced transit and travel restrictions, causing international trade and transportation to be hampered. As a result, the supply chain for small animal (in-vivo) imaging was interrupted, resulting in a temporary decrease in product demand. The market operators' capacity to offer small animal (in-vivo) imaging devices and apply previously sold products has been hampered by limited access to present and potential clients, resulting in a modest reduction in the growth rate in 2020. However, the supply chain disruption is projected to be mitigated in 2021, and the market is expected to develop at a faster rate during the projection period.

Small Animal (In-Vivo) Imaging Market Scope

The small animal (in-vivo) imaging market is segmented on the basis of modality, reagents, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Modality

• Optical Imaging Systems
• Nuclear Imaging Systems
• Micro-MRI
• Micro-Ultrasound
• Micro-CT
• Photoacoustic Imaging Systems
• Magnetic Particle Imaging Systems

Reagents

• Optical Imaging Reagents
• Nuclear Imaging Reagents
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Application

• Monitoring Drug treatment response
• Bio distribution Studies
• Cancer cell Detection
• Biomarkers
• Longitudinal Studies
• Epigenetics

Small Animal (In-Vivo) Imaging Market Regional Analysis

The small animal (in-vivo) imaging market is analyzed and market size insights and trends are provided by country, modality, reagents, and application as referenced above.

The countries covered in the small animal (in-vivo) imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the small animal (in-vivo) imaging market because of the innovative modality innovations resulting from technological advancements in this region. 

Europe is expected to grow during the forecast period due to the presence of large number of diagnostic device manufacturers in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Small Animal (In-Vivo) Imaging Market Share

소동물(생체 내) 이미징 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 소동물(생체 내) 이미징 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 소동물(체내) 이미징 시장 리더는 다음과 같습니다.

• 브루커(미국)
• 제너럴 일렉트릭(미국)
• Koninklijke Philips NV(네덜란드)
• 히타치 주식회사(일본)
• 지멘스 헬스케어 GmbH(독일)
• 후지필름 주식회사(일본)
• 브루커(미국)
• 퍼킨엘머 주식회사(미국)
• 밀테니 바이오텍(독일)
• CMR Naviscan(미국)
• SCANCO Medical AG(스위스)
• Aspect Imaging Ltd(이스라엘)
• 메디소 유한회사(VA)
• LI-COR, Inc (미국)
•  다카라바이오 주식회사(일본)
• MILabs BV(네덜란드)
• MR 솔루션(영국)
• 트리포일 이미징(미국)
• 뉴잉글랜드 바이오랩스(미국)
• 바이오스페이스 랩(프랑스)
• 게르베(프랑스)
• Agilent Technologies, Inc(미국)
• Thermo Fisher Scientific Inc(미국)

SKU-15653